Axon Enterprise has produced very strong long term share price gains over the past five years, yet the latest Discounted Cash Flow (DCF) intrinsic value estimate points to the stock trading at a steep premium while the broader valuation checks do not flag it as a clear bargain.

• Axon Enterprise has returned 246.9% over the past 5 years, which puts the current share price in focus for investors who already hold sizeable gains.
• Expectations for further revenue growth after the latest business update can support a higher valuation, but pressure on gross margins remains a key risk for how much of that growth turns into future cash flow.
• On Simply Wall St's broader valuation checks, Axon Enterprise scores 0 out of 6, which indicates the stock currently leans expensive rather than offering an obvious discount.

The issue now is whether Axon Enterprise's current price already reflects these growth expectations or still leaves room for further upside in the intrinsic value.

Is Axon Enterprise Getting Expensive on Cash Flow?

The Discounted Cash Flow (DCF) model estimates what Axon Enterprise might be worth based on its future cash generation. For the latest twelve months, Axon Enterprise produced around $136.8 million of free cash flow, and the model assumes that this figure grows over time rather than shrinks.

On those projections, the DCF model points to an intrinsic value of about $439 per share, which sits well below the current share price and implies the stock is roughly 44.9% overvalued. Because the recent earnings update highlighted lower gross margins even as revenue guidance increased, the market appears to be paying a high price for that growth while accepting margin risk.

On this cash flow view, Axon Enterprise stock currently screens as overvalued relative to its estimated intrinsic value.

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 44.9%. Discover 49 high quality undervalued stocks or create your own screener to find better value opportunities.

Does Axon Enterprise Look Fairly Valued on Sales?

P/S is often useful for Axon Enterprise because revenue is a key focus for the market as the company scales its platform. Axon Enterprise currently trades on a P/S ratio of about 16.1x, compared with an Aerospace & Defense industry average of around 5.0x and a peer group average near 5.6x. That is a clear premium to what investors are paying for revenue in the broader group.

The fair P/S ratio for Axon Enterprise is estimated at about 15.8x, which is only slightly below the current level. This suggests that, once factors such as growth profile, margins, size and risk are incorporated into the model, the present P/S multiple sits close to what might be expected for the stock.

On the P/S multiple, Axon Enterprise appears priced roughly in line with its modelled fair value rather than clearly cheap or clearly expensive.

The Axon Enterprise Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Axon Enterprise pick up where this valuation puzzle leaves off and explain what future growth, margins and earnings would need to look like for the stock to be worth materially more or less than today's price, all hosted on the Community page. Each narrative assigns a fair value to a particular set of potential catalysts and risks for Axon Enterprise's business so you can track which version of events appears to be unfolding over time.

Axon Enterprise now sits at the centre of two very different community narratives, with both sides agreeing on the importance of its platform but disagreeing on what that should mean for the stock.

Bull case: roughly fairly valued

"Fast-track adoption of new Axon products such as Draft One (AI), TASER 10, Axon Body 4, and Dedrone (counter-drone) is driving up average deal values and product bundles per customer..."

Bear case: roughly fairly valued

"What began as a hardware business is increasingly becoming an ecosystem built around digital evidence, cloud software, and connected policing tools..."

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

The Bottom Line

For Axon Enterprise, the Discounted Cash Flow (DCF) estimate points to the stock trading as overvalued, while the P/S based view sits closer to about right once growth and risk are factored in. That split reflects a market that is willing to pay up for revenue and product momentum, even though cash flow timing and margin pressure pull the intrinsic value estimate lower. Broader valuation checks remain weak, so the key question from here is whether Axon Enterprise can defend and improve margins enough for future cash generation to catch up with the price investors are already paying.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.